Veerhealth Care Share Price
Small Cap | Pharmaceuticals and health care | BSE: 511523
₹14.01 -0.45 (-3.11 %)
Last Updated: 25 Feb 2025 12:00 AM
Overview
Open (₹) 14.46
High (₹) 14.88
Low (₹) 13.99
Prev. Close (₹) 14.46
Volume 73,801
VWAP (₹) 14.16
ROCE (%) 5.08
Industry P/E 43.77
TTM P/E -467.00
P/B Ratio 1.28
Market Cap (₹) Cr.28.02
Dividend Yield (%)--
EPS (₹) 0.21
ROE1.92%
Sales Growth (%) -0.38
Profit Growth (%)-74.33
Day Range
14.8814.88
52 Week Range
13.9929.40
Historical Returns
Returns (6M)
-41.18 %
Returns (1Y)
-43.33 %
Returns (3Y)
159.44 %
Returns (5Y)
250.25 %
Returns (6M)
-41.18 %
Returns (1Y)
-43.33 %
Returns (3Y)
159.44 %
Returns (5Y)
250.25 %
SWOT Analysis
Technicals
Technical Rating
RSI 32.25
MFI 16.63
ATR 1.30
Commodity Channel Index -126.06
ROC125 -38.69
ROC21 -22.85
Williams %R -99.67
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 14.59 | 15.18 | 15.48 | 14.29 | 13.70 | 13.40 | 12.81 |
Week Ago | 15.85 | 16.35 | 16.70 | 15.50 | 15.00 | 14.65 | 14.15 |
Month Ago | 19.52 | 20.45 | 20.96 | 19.01 | 18.08 | 17.57 | 16.64 |
EMA & SMA
14.01
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 14.94
9 Day 15.47
10 Day 15.86
12 Day 16.39
14 Day 16.51
20 Day 17.08
26 Day 17.42
50 Day 18.85
100 Day 19.35
200 Day 20.93
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
SIDHESHBHAI DEVABHAI RAVAL | bulk | Sell | 16 Sept, 2024 | ₹24.52 | 1,27,473 | BSE |
JAYAKRISHNA TAPARIA | bulk | Sell | 16 Sept, 2024 | ₹24.00 | 1,17,988 | BSE |
SIDHESHBHAI DEVABHAI RAVAL | bulk | Buy | 16 Sept, 2024 | ₹24.00 | 1,27,473 | BSE |
VENKATESH PRASHANTH | bulk | Buy | 09 Aug, 2024 | ₹23.47 | 1,00,000 | BSE |
RAHUL YASHVANTRAY SHAH | bulk | Buy | 01 Aug, 2024 | ₹24.29 | 1,01,900 | BSE |
RAHUL YASHVANTRAY SHAH | bulk | Sell | 19 Jul, 2024 | ₹24.27 | 20,923 | BSE |
RAHUL YASHVANTRAY SHAH | bulk | Buy | 19 Jul, 2024 | ₹24.23 | 1,61,857 | BSE |
HARDIK INDRAMAL JAIN | bulk | Buy | 18 Jul, 2024 | ₹24.25 | 1,80,000 | BSE |
ARYAMAN BHARAT TAPARIA | bulk | Sell | 16 Jul, 2024 | ₹25.06 | 1,00,000 | BSE |
SIDHESHBHAI DEVABHAI RAVAL | bulk | Sell | 12 Jul, 2024 | ₹22.15 | 1,42,701 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
22 Mar, 2024 | Yogesh Mahasuklal Shah | Acquisition | ₹21.63 | 85,000 | BSE |
14 Mar, 2024 | Yogesh Mahasuklal Shah | Acquisition | ₹19.65 | 1,00,000 | BSE |
13 Mar, 2024 | Yogesh Mahasuklal Shah | Acquisition | ₹20.50 | 1,50,000 | BSE |
07 Mar, 2024 | Mahasuklal Shah HUF | Acquisition | ₹21.06 | 1,00,000 | BSE |
06 Mar, 2024 | Mahasuklal Shah HUF | Acquisition | ₹22.00 | 1,00,000 | BSE |
24 Feb, 2024 | Krupa Harsh Jain | Disposal | ₹27.31 | 5,00,000 | BSE |
23 Sept, 2022 | Mahasuklal Shah HUF | Disposal | ₹13.77 | 3,40,981 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
14 Aug, 2023 | Bonus issue in the ratio of 1:1 of Rs. 10/-. | 22 Sept, 2023 | 22 Sept, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
12 Feb, 2025 | BSE India | Please find attached herewith the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024. |
12 Feb, 2025 | BSE India | Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, we enclose the following:\r\n\r\n1. Statement showing unaudited financial results for the quarter and nine months ended December 31, 2024.\r\n2. Limited Review Report on unaudited financial results for the quarter and nine months ended December 31, 2024. |
12 Feb, 2025 | BSE India | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about outcome of the Meeting of Board of Directors of the Company held today i.e. February 12, 2025 as under:\r\n\r\n1. The Board has approved and taken on record the unaudited financial results for the quarter and nine months ended December 31, 2024.\r\n\r\nThe Board Meeting commenced at 4.00 p.m. and concluded at 4.40 p.m. |
04 Feb, 2025 | BSE India | Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter and nine months ended 31st December, 2024. |
06 Jan, 2025 | BSE India | Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended 31st December, 2024. |
20 Dec, 2024 | BSE India | Please find Outcome of Analyst/Investor meet. |
19 Dec, 2024 | BSE India | We are enclosing herewith the Press Release on introduction of new division in hospital care segment. |
18 Dec, 2024 | BSE India | Company is pleased to announce its introduction of new marketing division of hospital care segment. Under this new division, Company has associated with a leading manufacturer and exporter of Anesthesia Delivery Equipment, Air Compressors and Ambulances. This manufacturing Company mainly caters in the field of Operating Room, Critical Care, Life Support, Imaging and Mobile Healthcare.\r\n\r\nCompany has successfully marketed and supplied first lot of equipment having Ventilator, Defibrillator, Infusion Pump, Syringe Pump and other accessories to a government organization. Company will excel in this new line of business in the near future. |
14 Dec, 2024 | BSE India | Intimation of Analyst / Institutional Investor Meeting. |
12 Dec, 2024 | BSE India | We are enclosing herewith the Press Release on successful closure of assessment by USFDA of Form 4003 - \FDA Pre-Inspection Records Request\. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 05 Feb, 2025 | 12 Feb, 2025 |
Quarterly Results | -- | 07 Nov, 2024 | 14 Nov, 2024 |
Quarterly Results & Others | -- | 07 Aug, 2024 | 14 Aug, 2024 |
Audited Results & Final Dividend | -- | 22 May, 2024 | 30 May, 2024 |
Others | Inter alia, to consider, Examine, evaluate various options to raise funds by issue of Preference / Right shares along with Banking Loan for expansion. | 16 Feb, 2024 | 20 Feb, 2024 |
Quarterly Results & Others | Inter alia, to consider : Company is planning to do expansion and to meet up those Capital Expenditure, to consider capital raising options for the Company, as the Board may deem appropriate. | 05 Feb, 2024 | 10 Feb, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 08 Nov, 2023 |
Allotment of Equity shares | -- | 21 Sept, 2023 | 25 Sept, 2023 |
Quarterly Results, Bonus issue & A.G.M. | -- | 07 Aug, 2023 | 14 Aug, 2023 |
Audited Results & Dividend | -- | 16 May, 2023 | 22 May, 2023 |
Share Holding Pattern
Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
---|
About Veerhealth Care
Veerhealth Care is a Public Limited Listed company incorporated on 10/07/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L65910MH1992PLC067632 and registration number is 067632. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 13.22 Cr. and Equity Capital is Rs. 20.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1992
Managing Director
Mr. Bhavin S Shah
NSE Symbol
--
Veerhealth Care Management
Name | Designation |
---|---|
Mr. Yogesh M Shah | Chairman & Non-Exe.Director |
Mr. Bhavin S Shah | Managing Director |
Mrs. Shruti A Shah | Executive Director |
Mr. Chetan H Mehta | Independent Director |
Mr. Prakashbhai C Shah | Independent Director |
Mr. Nilesh K Shah | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,613.60 ₹1,639.50(-1.58%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,726.40 ₹5,702.55(0.42%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,463.35 ₹1,476.75(-0.91%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,342.10 ₹2,298.80(1.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,128.15 ₹1,164.55(-3.13%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Veerhealth Care
What is the share price of Veerhealth Care?
The share price of Veerhealth Care on 25 Feb, 2025 is ₹ 14.01.
What is 52W high and 52W low share price of Veerhealth Care?
The highest and lowest 52W share prices of Veerhealth Care are ₹ 30.100 and ₹ 16.610
What is the market cap of Veerhealth Care?
The market capitalization of Veerhealth Care as of 25 Feb, 2025 is ₹ 28.02 Crores
What is the P/E ratio of Veerhealth Care?
The current P/E ratio of Veerhealth Care as of 25 Feb, 2025 is 43.77
What is the PB ratio of Veerhealth Care?
The PB ratio of Veerhealth Care as of 25 Feb, 2025 is 1.28
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)